Travere therapeutics to present abstracts at the american society of nephrology (asn) kidney week 2023

Two late-breaking high-impact oral presentations of the phase 3 protect study of filspari ® (sparsentan) in igan and phase 3 duplex study of sparsentan in fsgs

TVTX Ratings Summary

TVTX Quant Ranking